Stay updated on ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a new build of the page history. The change updates the version shown on the page without altering study data or content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label on the page changed from v3.5.2 to v3.5.3, indicating a new release of the record history UI. This update is administrative and does not alter trial data or text.SummaryDifference0.1%

- Check46 days agoChange DetectedNew revision v3.5.2 was added and v3.5.0 was removed from the record history.SummaryDifference0.1%

- Check74 days agoChange Detected- Revision v3.5.0 added to the Record History, and revision v3.4.3 removed.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded Revision: v3.4.3 to the Record History and crossed out Revision: v3.4.2.SummaryDifference0.1%

- Check110 days agoChange DetectedRevision v3.4.2 was added to the history log and Revision v3.4.1 was removed. These are site-wide updates and notices rather than changes to trial data or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.